BACKGROUND Current clinical management of patients with pulmonary nodules involves either repeated low-dose CT (LDCT)/CT scans or invasive procedures, yet causes significant patient misclassification. An accurate noninvasive test is needed to identify malignant nodules and reduce unnecessary invasive tests.METHOD We developed a diagnostic model based on targeted DNA methylation sequencing of 389 pulmonary nodule patients’ plasma samples and then validation in 140 plasma samples independently. We tested the model in different stages and subtypes of pulmonary nodules.RESULTS A 100-feature model was developed and validated for pulmonary nodule diagnosis; the model achieved a receiver operating characteristic curve–AUC (ROC-AUC) of 0.843 on 140 independent validation samples, with an accuracy of 0.800. The performance was well maintained in (a) a 6 to 20 mm size subgroup (n = 100), with a sensitivity of 1.000 and adjusted negative predictive value (NPV) of 1.000 at 10% prevalence; (b) stage I malignancy (n = 90), with a sensitivity of 0.971; (c) different nodule types: solid nodules (n = 78) with a sensitivity of 1.000 and adjusted NPV of 1.000, part-solid nodules (n = 75) with a sensitivity of 0.947 and adjusted NPV of 0.983, and ground-glass nodules (n = 67) with a sensitivity of 0.964 and adjusted NPV of 0.989 at 10% prevalence. This methylation test, called PulmoSeek, outperformed PET-CT and 2 clinical prediction models (Mayo Clinic and Veterans Affairs) in discriminating malignant pulmonary nodules from benign ones.CONCLUSION This study suggests that the blood-based DNA methylation model may provide a better test for classifying pulmonary nodules, which could help facilitate the accurate diagnosis of early stage lung cancer from pulmonary nodule patients and guide clinical decisions.FUNDING The National Key Research and Development Program of China; Science and Technology Planning Project of Guangdong Province; The National Natural Science Foundation of China National.
Wenhua Liang, Zhiwei Chen, Caichen Li, Jun Liu, Jinsheng Tao, Xin Liu, Dezhi Zhao, Weiqiang Yin, Hanzhang Chen, Chao Cheng, Fenglei Yu, Chunfang Zhang, Luxu Liu, Hui Tian, Kaican Cai, Xiang Liu, Zheng Wang, Ning Xu, Qing Dong, Liang Chen, Yue Yang, Xiuyi Zhi, Hui Li, Xixiang Tu, Xiangrui Cai, Zeyu Jiang, Hua Ji, Lili Mo, Jiaxuan Wang, Jian-Bing Fan, Jianxing He
Title and authors | Publication | Year |
---|---|---|
LcProt: Proteomics‐based identification of plasma biomarkers for lung cancer multievent, a multicentre study
Liang H, Wang R, Cheng R, Ye Z, Zhao N, Zhao X, Huang Y, Jiang Z, Li W, Zheng J, Deng H, Jiang Y, Lin Y, Yan Y, Song L, Li J, Xu X, Liang W, Liu J, He J |
Clinical and Translational Medicine | 2025 |
Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer
Zhao M, Xue G, He B, Deng J, Wang T, Zhong Y, Li S, Wang Y, He Y, Chen T, Zhang J, Yan Z, Hu X, Guo L, Qu W, Song Y, Yang M, Zhao G, Yu B, Ma M, Liu L, Sun X, She Y, Xie D, Zhao D, Chen C |
Nature Communications | 2025 |
Development of a clinical prediction model for benign and malignant pulmonary nodules with a CTR ≥ 50% utilizing artificial intelligence-driven radiomics analysis
Shi W, Hu Y, Chang G, Qian H, Yang Y, Song Y, Wei Z, Gao L, Yi H, Wu S, Wang K, Huo H, Wang S, Mao Y, Ai S, Zhao L, Li X, Zheng H |
BMC Medical Imaging | 2025 |
Minimally invasive biomarkers for triaging lung nodules—challenges and future perspectives
Afridi WA, Picos SH, Bark JM, Stamoudis DA, Vasani S, Irwin D, Fielding D, Punyadeera C |
Cancer Metastasis Reviews | 2025 |
An integrated proteomic classifier to distinguish benign from malignant pulmonary nodules
Jia B, Wang T, Pan L, Du X, Yang J, Gao F, Liao L, Guo B, Dong J |
Clinical Proteomics | 2025 |
Integrating multimodal features to predict the malignancy of pulmonary ground−glass nodules: a multicenter prospective model development and validation study
Wei Y, Zhao W, Wu Z, Guo N, Wang M, Yu H, Wang Z, Shi W, Ma X, Li C, Ren J, Yin Y, Liu S, Yang Z, Chen LA |
Frontiers in Oncology | 2025 |
A multiomics dataset of paired CT image and plasma cell-free DNA end motif for patients with pulmonary nodules
Zhao M, Xue G, He B, Deng J, Wang T, Zhong Y, Li S, Wang Y, He Y, Chen T, Zhang J, Yan Z, Hu X, Guo L, Qu W, Song Y, Yang M, Zhao G, Yu B, Ma M, Liu L, Sun X, Zhao D, Xie D, Chen C, She Y |
Scientific Data | 2025 |
Computed tomography-guided percutaneous biopsy for diagnosing pulmonary nodules: a prospective, multicenter observational study.
Liu Y, Zhao L, Yu HL, Zhao W, Li D, Li GD, Wang H, Huo B, Huang QM, Liang BW, Ding R, Wang Z, Liu C, Deng LY, Xiong JR, Huang XQ, He C |
Journal of thoracic disease | 2025 |
Rapid and Noninvasive Early Detection of Lung Cancer by Integration of Machine Learning and Salivary Metabolic Fingerprints Using MS LOC Platform: A Large-Scale Multicenter Study.
Lin S, Yan R, Zhu J, Li B, Zhong Y, Han S, Wang H, Wu J, Chen Z, Jiang Y, Pan A, Huang X, Chen X, Zhu P, Cao S, Liang W, Ye P, Gao Y |
Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2025 |
An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing
Zhang X, Yin Y, Ye Z, Zhang X, Wei W, Hao Y, Zeng L, Yang T, Li D, Wang J, Zhao D, Chen Y, Lei S, Jiang Y, Zhang Y, Xu S, Nanding A, Gong Y, Li S, Yu Y, Zhao S, Liu S, Zhao Y, Chen Z, Yu S, Fan J, Pang D |
Cancer Medicine | 2025 |
Innovative technologies and their clinical prospects for early lung cancer screening
Deng Z, Ma X, Zou S, Tan L, Miao T |
Clinical and Experimental Medicine | 2025 |
A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma.
Li M, Deng X, Zhou D, Liu X, Dai J, Liu Q |
Current genomics | 2024 |
Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.
Akram F, Tanveer R, Andleeb S, Shah FI, Ahmad T, Shehzadi S, Akhtar AM, Syed G |
Technology in cancer research & treatment | 2024 |
DNA methylation in human diseases
Younesian S, Mohammadi MH, Younesian O, Momeny M, Ghaffari SH, Bashash D |
Heliyon | 2024 |
Adaptive medicine, a crucial component of optimized decision making: perspectives from lung cancer management
Liang W, Zhong R, He J |
Translational Lung Cancer Research | 2024 |
Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodules
Liang P, Peng M, Tao J, Wang B, Wei J, Lin L, Cheng B, Xiong S, Li J, Li C, Yu Z, Li C, Wang J, Li H, Chen Z, Fan J, Liang W, He J |
MedComm | 2024 |
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology.
Tan WY, Nagabhyrava S, Ang-Olson O, Das P, Ladel L, Sailo B, He L, Sharma A, Ahuja N |
Current issues in molecular biology | 2024 |
Discrimination of Lung Cancer and Benign Lung Diseases Using BALF Exosome DNA Methylation Profile
Batochir C, Kim IA, Jo EJ, Kim EB, Kim HJ, Hur JY, Kim DW, Park HK, Lee KY |
Cancers | 2024 |
A clinically applicable model more suitable for predicting malignancy or benignity of pulmonary ground glass nodules in women patients.
Zhu X, Shen C, Dong J |
BMC cancer | 2024 |
A clinically effective model based on cell-free DNA methylation and low-dose CT for risk stratification of pulmonary nodules.
Liang W, Tao J, Cheng C, Sun H, Ye Z, Wu S, Guo Y, Zhang J, Chen Q, Liu D, Liu L, Tian H, Teng L, Zhong N, Fan JB, He J |
Cell reports. Medicine | 2024 |
Clinical application of ctDNA in early diagnosis, treatment and prognosis of patients with non-small cell lung cancer.
Zhu S, Wu R, Liu X, Xie B, Xie C, Li S, Wu Z, Zhang Z, Tang Z, Gu L |
Future oncology (London, England) | 2024 |
Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging features.
Yang M, Yu H, Feng H, Duan J, Wang K, Tong B, Zhang Y, Li W, Wang Y, Liang C, Sun H, Zhong D, Wang B, Chen H, Gong C, He Q, Su Z, Liu R, Zhang P |
Journal of translational medicine | 2024 |
Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges
Li L, Sun Y |
MedComm | 2024 |
Mex3a promoter hypomethylation can be utilized to diagnose HBV-associated hepatocellular carcinoma: a randomized controlled trial.
Yang JR, Tian YX, Li JE, Zhang Y, Fan YC, Wang K |
Frontiers in pharmacology | 2024 |
General anesthesia induces acute cell-free DNA methylation changes in peripheral blood
Liang W, Liu X, Chen Z, Wang H, Yu Z, Li C, Yang H, Tao J, Li H, Chen Z, Fan JB, He J |
Journal of Thoracic Disease | 2024 |
Identifying targeted cell-free DNA methylation regions in head and neck cancer via paired methylome analysis
Li T, Patel KB, Yu X, Yao S, Wang L, Chung CH, Wang X |
Research Square | 2024 |
Multisite DNA methylation alterations of peripheral blood mononuclear cells serve as novel biomarkers for the diagnosis of AIS/stage I lung adenocarcinoma: a multicenter cohort study
Li P, Liu S, Wang T, Wang F, Li J, Qi Q, Zhang S, Xie Y, Li J, Zhu Y, Yang S, Yin G, He X, Li S, Xu H, Xiong M, Li G, Zhang Y, Du L, Wang C |
International Journal of Surgery (London, England) | 2024 |
Serum laser Raman spectroscopy as a potential diagnostic tool to discriminate the benignancy or malignancy of pulmonary nodules
Huaichao Luo, Ruiling Zu, Lintao Li, Yao Deng, Shuya He, Xing Yin, Kaijiong Zhang, Qiao He, Yu Yin, Gang Yin, Dezhong Yao, Dongsheng Wang |
iScience | 2023 |
Artificial Intelligence Assisted Computational Tomographic Detection of Lung Nodules for Prognostic Cancer Examination: A Large-Scale Clinical Trial
Chao HS, Tsai CY, Chou CW, Shiao TH, Huang HC, Chen KC, Tsai HH, Lin CY, Chen YM |
Biomedicines | 2023 |
Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma
Li J, Li J, Hao H, Lu F, Wang J, Ma M, Jia B, Zhuo M, Wang J, Chi Y, Zhai X, Wang Y, Wu M, An T, Zhao J, Yang F, Wang Z |
BMC Cancer | 2023 |
pfeRNAs- a Novel Class of Small Non-coding RNAs with Real Translational Potential
Mei Y, Khan H, Shishikura M, Ishiyama S, Khan A, Orita H, Brock MV |
The Journal of surgical research | 2023 |
Unveiling targeted cell-free DNA methylation regions through paired methylome analysis of tumor and normal tissues
Li T, Patel KB, Yu X, Yao S, Wang L, Chung CH, Wang X |
2023 | |
Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk Assessment
Lastwika KJ, Wu W, Zhang Y, Ma N, Zečević M, Pipavath SN, Randolph TW, Houghton AM, Nair VS, Lampe PD, Kinahan PE |
Cancers | 2023 |
CTCs Detection and Whole-exome Sequencing Might Be Used to Differentiate Benign and Malignant Pulmonary Nodules
XU C, XU X, SHAO W, SUN H, LIU X, FENG H, ZUO X, GAO J, WANG G, YANG X, GU R, GE S, WANG S, GAO L, ZHU G |
2023 | |
DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers
Coppedè F, Bhaduri U, Stoccoro A, Nicolì V, Di Venere E, Merla G |
International journal of molecular sciences | 2023 |
A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer
Zhang J, Yao H, Lai C, Sun X, Yang X, Li S, Guo Y, Luo J, Wen Z, Tang K |
Chinese Journal of Cancer Research | 2023 |
Noninvasive diagnosis of pulmonary nodules using a circulating tsRNA-based nomogram.
Wang Q, Song X, Zhao F, Chen Q, Xia W, Dong G, Xu L, Mao Q, Jiang F |
Cancer Science | 2023 |
Liquid biopsy for early detection of lung cancer
Bibikova M, Fan J |
Chinese Medical Journal Pulmonary and Critical Care Medicine | 2023 |
Towards zero lung cancer
Liang W, He J, Zhong N |
Chinese Medical Journal Pulmonary and Critical Care Medicine | 2023 |
A novel DNA methylation signature associated with lymph node metastasis status in early gastric cancer
S Chen, Y Yu, T Li, W Ruan, J Wang, Q Peng, Y Yu, T Cao, W Xue, X Liu, Z Chen, J Yu, J Fan |
Clinical Epigenetics | 2022 |
Integrative serum metabolic fingerprints based multi-modal platforms for lung adenocarcinoma early detection and pulmonary nodule classification
Lin Wang, Mengji Zhang, Xufeng Pan, Mingna Zhao, Lin Huang, Xiaomeng Hu, Xueqing Wang, Lihua Qiao, Qiaomei Guo, Wanxing Xu, Wenli Qian, Tingjia Xue, Xiaodan Ye, Ming Li, Haixiang Su, Yinglan Kuang, Xing Lu, Xin Ye, Kun Qian, Jiatao Lou |
Advanced Science | 2022 |
Circulating cell-free DNA for cancer early detection
Gao Q, Zeng Q, Wang Z, Li C, Xu Y, Cui P, Zhu X, Lu H, Wang G, Cai S, Wang J, Fan J |
2022 | |
A new classifier constructed with platelet features for malignant and benign pulmonary nodules based on prospective real-world data
Zu R, Wu L, Zhou R, wen X, Cao B, Liu S, Yang G, Leng P, Li Y, Zhang L, Song X, Deng Y, Zhang K, Liu C, Li Y, Huang J, Wang D, zhu G, Luo H |
Journal of Cancer | 2022 |
Advances in lung cancer screening and early detection
Li C, Wang H, Jiang Y, Fu W, Liu X, Zhong R, Cheng B, Zhu F, Xiang Y, He J, Liang W |
Cancer biology & medicine | 2022 |
Adding predictive and diagnostic values of pulmonary ground-glass nodules on lung cancer via novel non-invasive tests
Ding Y, He C, Zhao X, Xue S, Tang J |
Frontiers in Medicine | 2022 |
Characteristics and significance of peripheral blood T-cell receptor repertoire features in patients with indeterminate lung nodules
Luo H, Zu R, Huang Z, Li Y, Liao Y, Luo W, Zhou P, Wang D, Chen S, Li W, Huang J |
Signal Transduction and Targeted Therapy | 2022 |
Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25
Qi Y, Qiu Z, Zhang C, Fu R, Yang X, Chu X, Chen Z, Yang X, Wu Y, Zhong W |
Thoracic Cancer | 2022 |
Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer.
Shen H, Jin Y, Zhao H, Wu M, Zhang K, Wei Z, Wang X, Wang Z, Li Y, Yang F, Wang J, Chen K |
BMC Medicine | 2022 |
Integration of the blood test into the low-dose computed tomography lung cancer screening: reliable discrimination between malignant and non-malignant radiographic findings
ES Kuligina, AG Iyevleva, EN Imyanitov |
Translational Lung Cancer Research | 2021 |
Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids
L Li, Z Ye, S Yang, H Yang, J Jin, Y Zhu, J Tao, S Chen, J Xu, Y Liu, W Liang, B Wang, M Yang, Q Huang, Z Chen, W Li, JB Fan, D Liu |
Clinical Epigenetics | 2021 |
Diagnostic value of conventional tumor markers in young patients with pulmonary nodules
L Xu, Z Su, B Xie |
Journal of Clinical Laboratory Analysis | 2021 |
A Cost-Effective and Non-Invasive pfeRNA-Based Test Differentiates Benign and Suspicious Pulmonary Nodules from Malignant Ones
W Liu, Y Wang, H Huang, N Fackche, K Rodgers, B Lee, W Nizam, H Khan, Z Lu, X Kong, Y Li, N Liang, X Zhao, X Jin, H Liu, CC Talbot, P Huang, JR Eshleman, Q Lai, Y Zhang, MV Brock, Y Mei |
Non-Coding RNA | 2021 |
Overview of recent advances in molecular analysis for diagnosing early stage lung cancer nodules
M Frattini, P Froesch, S Epistolio |
Translational Lung Cancer Research | 2021 |